About DNASense
DNASense is a company based in Aalborg (Denmark) founded in 2014 by Mads Albertsen was acquired by Clinical Microbiomics in March 2024. The company has 8 employees as of November 30, 2024. DNASense offers products and services including Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and Microbial source tracking. DNASense operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
- Headquarter Aalborg, Denmark
- Employees 8 as on 30 Nov, 2024
- Founders Mads Albertsen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dnasense Aps
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
8
as on Nov 30, 2024
-
Acquired by
Clinical Microbiomics
(Mar 01, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DNASense
DNASense offers a comprehensive portfolio of products and services, including Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and Microbial source tracking.
Targeted sequencing to identify microbial communities and their abundance.
Provides annotated microbial genomes for metabolic potential analysis.
Whole-genome sequencing to uncover microbial community structures.
RNA sequencing for quantifying transcripts in microbial samples.
Sequencing to track and pinpoint sources of microbial outbreaks.
Assists with data sharing and figure customization for publications.
Funding Insights of DNASense
Detailed funding history for DNASense
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DNASense
DNASense has secured backing from 1 investor. Prominent investors backing the company include Clinical Microbiomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Meta-genomics platforms and services for microbiome studies are provided.
|
Locked | Locked | Locked |
Investor details for DNASense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DNASense
Investment portfolio details for DNASense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DNASense
Detailed financials for DNASense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dnasense Comparisons
Peer comparison for DNASense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DNASense
DNASense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
Genome sequencing, analysis, and genetic screening services are provided.
|
Detailed competitors of DNASense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dnasense
Complete news archive for DNASense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DNASense
DNASense was founded in 2014.
DNASense is headquartered in Aalborg, Denmark.
Mads Albertsen is the current CEO of DNASense. They have also founded this company.
As of Nov 30, 2024, the latest employee count at DNASense is 8.
DNASense was established in 2014 in Aalborg, Denmark, within the biotechnology sector. Genetic engineering services are delivered by the company, covering bacteria and archaea community profiling, fungi community profiling, sequencing, metagenomics, bioinformatics analysis, gene expression profiling, and biobank operations. These activities support research and analysis in microbial and genetic fields across various applications.
DNASense's top competitors include Novogene Corporation, Source BioScience and Genewiz.
DNASense offers Microbial marker gene analysis, Genomics, Metagenomics, Metatranscriptomics, and 2 more products and services.
DNASense has 1 investor. Key investors include Clinical Microbiomics.